Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase

He-ping Xie; Hong-zhi Yang; Wei-kang Wu; Wei-bing Guan; Qian-shan Ke; Yong-wei Li; Min Dai; Ge-min Xiao; Jiong-shan Zhang; Yang-mei Li

doi:10.1007/s11655-013-1569-5

Your Location：

Home >

Browse articles >

Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase

OriginalPaper | Updated：2021-08-27

- Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase
- Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase
- 中国结合医学杂志（英文版） 2014年20卷第2期页码：94-100
- Affiliations：
  
  Traditional Chinese Medicine & Acupuncture Department, The Third Affiliated Hospital of Sun Yet-sen University,Guangzhou,China
- Author bio：
- Funds：
  
  Supported by Grants from the National Major Projects for AIDS and Viral Hepatitis of China (No.2008ZX10005-008)
- DOI：10.1007/s11655-013-1569-5
  中图分类号：
- 纸质出版日期：2014，
  
  网络出版日期：2014-3-6，
Scan for full text
Xie, Hp., Yang, Hz., Wu, Wk. et al. Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase., Chin. J. Integr. Med. 20, 94–100 (2014). https://doi.org/10.1007/s11655-013-1569-5

He-ping Xie, Hong-zhi Yang, Wei-kang Wu, et al. Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase[J]. Chinese Journal of Integrative Medicine, 2014,20(2):94-100.
Xie, Hp., Yang, Hz., Wu, Wk. et al. Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase., Chin. J. Integr. Med. 20, 94–100 (2014). https://doi.org/10.1007/s11655-013-1569-5 DOI：

He-ping Xie, Hong-zhi Yang, Wei-kang Wu, et al. Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase[J]. Chinese Journal of Integrative Medicine, 2014,20(2):94-100. DOI： 10.1007/s11655-013-1569-5.

摘要

To explore Chinese medicine (CM) syndrome distribution of chronic hepatitis B virus (HBV) carriers in immunotolerant phase (ITP). One hundred and eighty-five chronic HBV carriers in ITP

seen in the Third Affiliated Hospital of Sun Yat-sen University from May 2009 to December 2010

were admitted in an observational study under the guidance of CM. Patients’ CM symptoms and signs

demographics

liver biochemistries

and qualitative HBV DNA were recorded in the questionnaires. CM syndromes were then differentiated to 15 detailed types and analyzed by generalization. Lastly

the location

pathogenic factors and nature of the disease were also assessed. When CM syndrome patterns were differentiated to 15 types

there were 27 (15%) no syndrome cases

94 (50%) single syndrome cases and 64 (35%) compound syndromes cases. The main detailed syndromes included Liver (Gan)-qi depression (LQD)

Kidney (Shen)-qi deficiency (KQD)

Spleen (Pi)-qi deficiency (SQD) and Kidney-yang deficiency (KYAD). After CM syndromes generalized to five types

their frequency was Spleen-Kidney deficiency (SKD)>LQD>inner dampness-heat retention (IDHR)>Liver-Kidney deficiency (LKD)>blood stasis blocking collateral (BSBC). SKD and LQD occupied 64%. The disease location included Liver

Gallbladder (Dan)

Spleen

Stomach (Wei) and Kidney. The pathogenic factors were mainly qi stagnation

qi deficiency

yang deficiency

concurrently dampness-heat and blood stasis. The deficiency syndrome was more than excess syndrome in its nature. Most of chronic HBV carriers in ITP have their CM syndrome

and the most common types are SKAD

LQD. This study suggests that the natural history may be improved through breaking the state of immune tolerance or shorten the time of ITP by strengthening Spleen-Kidney and reliving Liver qi.

Abstract

To explore Chinese medicine (CM) syndrome distribution of chronic hepatitis B virus (HBV) carriers in immunotolerant phase (ITP). One hundred and eighty-five chronic HBV carriers in ITP

seen in the Third Affiliated Hospital of Sun Yat-sen University from May 2009 to December 2010

were admitted in an observational study under the guidance of CM. Patients’ CM symptoms and signs

demographics

liver biochemistries

and qualitative HBV DNA were recorded in the questionnaires. CM syndromes were then differentiated to 15 detailed types and analyzed by generalization. Lastly

the location

pathogenic factors and nature of the disease were also assessed. When CM syndrome patterns were differentiated to 15 types

there were 27 (15%) no syndrome cases

94 (50%) single syndrome cases and 64 (35%) compound syndromes cases. The main detailed syndromes included Liver (Gan)-qi depression (LQD)

Kidney (Shen)-qi deficiency (KQD)

Spleen (Pi)-qi deficiency (SQD) and Kidney-yang deficiency (KYAD). After CM syndromes generalized to five types

Gallbladder (Dan)

Spleen

Stomach (Wei) and Kidney. The pathogenic factors were mainly qi stagnation

qi deficiency

yang deficiency

concurrently dampness-heat and blood stasis. The deficiency syndrome was more than excess syndrome in its nature. Most of chronic HBV carriers in ITP have their CM syndrome

and the most common types are SKAD

LQD. This study suggests that the natural history may be improved through breaking the state of immune tolerance or shorten the time of ITP by strengthening Spleen-Kidney and reliving Liver qi.

关键词

hepatitis B virus carriernatural historyimmune toleranceChinese MedicineSyndrome Differentiation

Keywords

hepatitis B virus carriernatural historyimmune toleranceChinese MedicineSyndrome Differentiation

references

Liu J, Fan DM. He patitis Bin China. Lancet 2007;369:1582–1583.

Liaw YF. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 2009;51:403–410.

Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010;14:1–21, vii.

World Health Organization. Hepatitis B. World Health Organization Fact Sheet No. 204 Revised October 2000. Available at: http://www.who.int/mediacentre/factsheets/fs204/en.

Cornberg M, Jaroszewicz J, Manns MP, Wedemeyer H. Treatment of chronic hepatitis B. Minerva Gastroenterol Dietol 2010;56:451–465.

Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virusinduced hepatocellular carcinoma. Pathol Biol (Paris) 2010;58:273–277.

Heathcote EJ. Demography and presentation of chronic hepatitis B virus infection. Am J Med 2008;121(12 Suppl):S3–S11.

Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009;50:264–272.

Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582–592.

Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107.

Ohkawa K, Takehara T, Tatsumi T, Ishida H, Deguchi M, Kagita M, et al. Alterations in hepatitis B virus nucleotide sequences in a chronic virus carrier from immunotolerant to immunoactive phase. Biochem Biophys Res Commun 2010;394:574–580.

Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335–352.

Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int 2009;29(Suppl 1):100–107.

Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942–1956.

Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191–211, v.

Chen LY, Lv WL. Traditional and Western medicine progress of HBV carrier state. Chin J Integr Tradit West Med (Chin) 2008;28:379–381.

Zhu LL, Meng H, Jiang J, Gao YQ. Study on CM syndrome typing of chronic hepatitis B. Chin J Integr Tradit West Med (Chin) 2008;28:20–23.

Ye YA, Jiang F, Zhao ZM, Li ZH, Zhang L, Liu HQ, et al. Chinese medical pattern distribution of chronic type hepatitis B. J Tradit Chin Med (Chin) 2007;48:256–258.

Xu FL. Literatures’ evaluation on CM syndrome types of chronic hepatitis B. J Clin Hepatol 2008;11:109–112.

Yu CG, Wang TF, Wan X, Zhao Y, Li ZG, Yin YJ, et al. Analysis on common syndrome manifestations and syndrome factors of chronic hepatitis B. J Beijing Univ Tradit Chin Med (Chin) 2005;28:70–73.

Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B. Chin J Hepatol (Chin) 2005;13:881–891.

European Association for The Study of The LEASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227–242.

Yang HZ, Zhao JA, Dai M, Li YW, Wang YZ, Guan WB, et al. Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant. World J Gastroenterol 2005;11:2004–2008.

Zheng XY, ed. Guiding principle for clinical research on new drugs of traditional Chinese medicine. Beijing: China Medic-Pharmaeeutical Sciences and Technology Publishing House; 2002:361–388.

Zhu WF, ed. Diagnostics of traditional Chinese medicine. Beijing: China Press of Traditional Chinese Medicine; 2007:139–203.

Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune tolerant phase. Hepatology 2007;46:395–401.

Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 Version). Chin J Gastroenterol 2011;16:351–366.

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009;27:6550–6557.

Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J 2009;122:3–4.

Yang LS, Wang QP, Zhou JG, Jiang DX, Li SL, Su YY, et al. Study on Chinese medical syndromes of subhealth state in HBV carriers. Acta Univ Tradit Med Sinen Pharmacol Shanghai (Chin) 2008;22:34–37.

Yang LS, Wang QP, Zhou JG, Jiang DX, Li SL, Su YY, et al. Study on CM syndrome types of HBV carrier in second health condition. Chin J Integr Tradit West Med Liver Dis (Chin) 2008;18:71–73.

Mao DX, Zhu G. Ideas for syndrome differentiating and Chinese herbs using in hepatitis B. J Tradit Chin Med (Chin) 2002;43:144–145.

Yuan JQ. Chinese medicine therapeutic and understanding measurements for HBV infection in the phase of immune tolerance. Chin J Integr Tradit West Med Liver Dis (Chin) 2007;17:65–67.

Hu ZY. Progress in the mechanism of persistent HBV infection. Foreign Med Sci (Virology, Chin) 2000;7:100–103.

Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology 2009;50:661–662.

Song J, Chen KJ. Set clinical therapeutic guideline in traditional medicine urgently. Chin J Integr Tradit West Med (Chin) 2006;26:581–584.

Yang HZ, Wang FL, Wang YZ, Shen WS, Xu GL, Yang YW, et al. The clinical study on cronic hepatitis B treated by the four-step therapeutics of traditional Chinese medicine. J Chin Med Mater (Chin) 2006;29:748–752.

FULL TEXT LINK

More>

浏览量

753

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Potential of renal pathology on refining syndrome typing of Chinese medicine in IgA nephropathy

Effect of treatment based on syndrome differentiation by Chinese medicine on post-traumatic elbow arthritis

Approaches of toxicity-reducing and efficacy-enhancing in tumor patients treated with radio- and chemotherapy

Acupuncture for chronic non-specific low back pain: A case series study

Acupuncture points used in the prophylaxis against recurrent uncomplicated cystitis, patterns identified and their possible relationship to physiological measurements